Back

Adverse chromatin remodelling by SETD7 drives inflammation and diastolic dysfunction in obese heart failure with preserved ejection fraction

30 August 2025 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Basic and Translational Sciences Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shafeeq Ahmed Mohammed

University Hospital Zurich, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Gene therapy for short QT syndrome type 1 (SQT1): a proof-of-concept efficacy trial in transgenic SQT1 rabbits
Doctor S. Nimani (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Human heart-tumor interaction in ischemic / failing heart is mediated by cardiac mesenchymal stromal cells
Mr T. Caller (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Asxl1 clonal hematopoiesis exacerbates heart failure via the NEAT1-inflammasome axis
Doctor A. Shindo (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Basic and Translational Sciences
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Chromatin remodeling by the histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction
thumbnail
Congress Session
The epigenome in heart failure: from mechanisms to epi-drugs
thumbnail
Congress Presentation
Chromatin-editing drugs in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources